# L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome

> **NCT01603446** · PHASE2 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 7 (actual)

## Conditions studied

- MELAS Syndrome

## Interventions

- **DRUG:** L-Arginine

## Key facts

- **NCT ID:** NCT01603446
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-05
- **Final completion:** 2013-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2013-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603446, "L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01603446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*